Report Detail
Global Dry Powder Inhaler Device Market Growth 2019-2024
- RnM2975387 |
- 18 February, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Other
A dry powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder. DPIs are commonly used to treat respiratory diseases such as asthma, bronchitis, emphysema and COPD although DPIs (such as inhalable insulin Afrezza) have also been used in the treatment of diabetes mellitus.
The global total sales of dry powder inhaler device is nearly 49674 K units in 2015.
As a high tech industry, the manufacturing technology of Dry Powder Inhaler Device is mature but only these international giants can supply the high-end products with excellent performance. There is still a core technical barrier.
Today, the price of Dry Powder Inhaler Device is lower than past years. The reason for this downward trend of price is the development of technology and the price fluctuations of raw materials. In future, the price would go down continuously and slowly.
According to this study, over the next five years the Dry Powder Inhaler Device market will register a 4.9% CAGR in terms of revenue, the global market size will reach US$ 820 million by 2024, from US$ 640 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Dry Powder Inhaler Device business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Dry Powder Inhaler Device market by product type, application, key manufacturers and key regions and countries.
This study considers the Dry Powder Inhaler Device value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Single Dose
Multi-dose
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Asthma
COPD
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Chiesi
Cipla
3M
Hovione
Mannkind
Meda
Novartis
Schering/Merck
Teva
Vectura
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Dry Powder Inhaler Device consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Dry Powder Inhaler Device market by identifying its various subsegments.
Focuses on the key global Dry Powder Inhaler Device manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Dry Powder Inhaler Device with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Dry Powder Inhaler Device submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Dry Powder Inhaler Device Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Dry Powder Inhaler Device Consumption 2014-2024
- 2.1.2 Dry Powder Inhaler Device Consumption CAGR by Region
- 2.2 Dry Powder Inhaler Device Segment by Type
- 2.2.1 Single Dose
- 2.2.2 Multi-dose
- 2.3 Dry Powder Inhaler Device Consumption by Type
- 2.3.1 Global Dry Powder Inhaler Device Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Dry Powder Inhaler Device Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Dry Powder Inhaler Device Sale Price by Type (2014-2019)
- 2.4 Dry Powder Inhaler Device Segment by Application
- 2.4.1 Asthma
- 2.4.2 COPD
- 2.4.3 Other
- 2.5 Dry Powder Inhaler Device Consumption by Application
- 2.5.1 Global Dry Powder Inhaler Device Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Dry Powder Inhaler Device Value and Market Share by Application (2014-2019)
- 2.5.3 Global Dry Powder Inhaler Device Sale Price by Application (2014-2019)
3 Global Dry Powder Inhaler Device by Players
- 3.1 Global Dry Powder Inhaler Device Sales Market Share by Players
- 3.1.1 Global Dry Powder Inhaler Device Sales by Players (2017-2019)
- 3.1.2 Global Dry Powder Inhaler Device Sales Market Share by Players (2017-2019)
- 3.2 Global Dry Powder Inhaler Device Revenue Market Share by Players
- 3.2.1 Global Dry Powder Inhaler Device Revenue by Players (2017-2019)
- 3.2.2 Global Dry Powder Inhaler Device Revenue Market Share by Players (2017-2019)
- 3.3 Global Dry Powder Inhaler Device Sale Price by Players
- 3.4 Global Dry Powder Inhaler Device Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Dry Powder Inhaler Device Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Dry Powder Inhaler Device Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Dry Powder Inhaler Device by Regions
- 4.1 Dry Powder Inhaler Device by Regions
- 4.1.1 Global Dry Powder Inhaler Device Consumption by Regions
- 4.1.2 Global Dry Powder Inhaler Device Value by Regions
- 4.2 Americas Dry Powder Inhaler Device Consumption Growth
- 4.3 APAC Dry Powder Inhaler Device Consumption Growth
- 4.4 Europe Dry Powder Inhaler Device Consumption Growth
- 4.5 Middle East & Africa Dry Powder Inhaler Device Consumption Growth
5 Americas
- 5.1 Americas Dry Powder Inhaler Device Consumption by Countries
- 5.1.1 Americas Dry Powder Inhaler Device Consumption by Countries (2014-2019)
- 5.1.2 Americas Dry Powder Inhaler Device Value by Countries (2014-2019)
- 5.2 Americas Dry Powder Inhaler Device Consumption by Type
- 5.3 Americas Dry Powder Inhaler Device Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Dry Powder Inhaler Device Consumption by Countries
- 6.1.1 APAC Dry Powder Inhaler Device Consumption by Countries (2014-2019)
- 6.1.2 APAC Dry Powder Inhaler Device Value by Countries (2014-2019)
- 6.2 APAC Dry Powder Inhaler Device Consumption by Type
- 6.3 APAC Dry Powder Inhaler Device Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Dry Powder Inhaler Device by Countries
- 7.1.1 Europe Dry Powder Inhaler Device Consumption by Countries (2014-2019)
- 7.1.2 Europe Dry Powder Inhaler Device Value by Countries (2014-2019)
- 7.2 Europe Dry Powder Inhaler Device Consumption by Type
- 7.3 Europe Dry Powder Inhaler Device Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Dry Powder Inhaler Device by Countries
- 8.1.1 Middle East & Africa Dry Powder Inhaler Device Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Dry Powder Inhaler Device Value by Countries (2014-2019)
- 8.2 Middle East & Africa Dry Powder Inhaler Device Consumption by Type
- 8.3 Middle East & Africa Dry Powder Inhaler Device Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Dry Powder Inhaler Device Distributors
- 10.3 Dry Powder Inhaler Device Customer
11 Global Dry Powder Inhaler Device Market Forecast
- 11.1 Global Dry Powder Inhaler Device Consumption Forecast (2019-2024)
- 11.2 Global Dry Powder Inhaler Device Forecast by Regions
- 11.2.1 Global Dry Powder Inhaler Device Forecast by Regions (2019-2024)
- 11.2.2 Global Dry Powder Inhaler Device Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Dry Powder Inhaler Device Forecast by Type
- 11.8 Global Dry Powder Inhaler Device Forecast by Application
12 Key Players Analysis
- 12.1 GlaxoSmithKline
- 12.1.1 Company Details
- 12.1.2 Dry Powder Inhaler Device Product Offered
- 12.1.3 GlaxoSmithKline Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 GlaxoSmithKline News
- 12.2 AstraZeneca
- 12.2.1 Company Details
- 12.2.2 Dry Powder Inhaler Device Product Offered
- 12.2.3 AstraZeneca Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 AstraZeneca News
- 12.3 Boehringer Ingelheim
- 12.3.1 Company Details
- 12.3.2 Dry Powder Inhaler Device Product Offered
- 12.3.3 Boehringer Ingelheim Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Boehringer Ingelheim News
- 12.4 Chiesi
- 12.4.1 Company Details
- 12.4.2 Dry Powder Inhaler Device Product Offered
- 12.4.3 Chiesi Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Chiesi News
- 12.5 Cipla
- 12.5.1 Company Details
- 12.5.2 Dry Powder Inhaler Device Product Offered
- 12.5.3 Cipla Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Cipla News
- 12.6 3M
- 12.6.1 Company Details
- 12.6.2 Dry Powder Inhaler Device Product Offered
- 12.6.3 3M Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 3M News
- 12.7 Hovione
- 12.7.1 Company Details
- 12.7.2 Dry Powder Inhaler Device Product Offered
- 12.7.3 Hovione Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Hovione News
- 12.8 Mannkind
- 12.8.1 Company Details
- 12.8.2 Dry Powder Inhaler Device Product Offered
- 12.8.3 Mannkind Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Mannkind News
- 12.9 Meda
- 12.9.1 Company Details
- 12.9.2 Dry Powder Inhaler Device Product Offered
- 12.9.3 Meda Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Meda News
- 12.10 Novartis
- 12.10.1 Company Details
- 12.10.2 Dry Powder Inhaler Device Product Offered
- 12.10.3 Novartis Dry Powder Inhaler Device Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Novartis News
- 12.11 Schering/Merck
- 12.12 Teva
- 12.13 Vectura
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Dry Powder Inhaler Device . Industry analysis & Market Report on Dry Powder Inhaler Device is a syndicated market report, published as Global Dry Powder Inhaler Device Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Dry Powder Inhaler Device market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
